# A Study of Divalproex Sodium in Children With ASD and Epileptiform EEG

> **NCT01170325** · PHASE2 · WITHDRAWN · sponsor: **National Institute of Mental Health (NIMH)**

## Conditions studied

- Autism
- Autism Spectrum Disorders

## Interventions

- **DRUG:** Divalproex Sodium
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01170325
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-06-30
- **Primary completion:** 2011-01-28
- **Final completion:** 2011-01-28
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01170325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01170325, "A Study of Divalproex Sodium in Children With ASD and Epileptiform EEG". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01170325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*